Brief: Ac Immune Partner LMI Progresses Tau PET Tracer PI-2620 Into Late-Stage Development In Alzheimer’S Disease
26/09/2022 14:15
Sept 26 (Reuters) - AC Immune SA ACIU.O :
* AC IMMUNE PARTNER LMI PROGRESSES TAU PET TRACER PI-2620
INTO
LATE-STAGE DEVELOPMENT IN ALZHEIMER’S DISEASE
* AC IMMUNE SA - AS PART OF AGREEMENT WITH AC IMMUNE, LMI
WILL
MAKE A MILESTONE PAYMENT.
Source text for Eikon: ID:nGNXbCTxMf
Further company coverage: ACIU.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on AC Immune AG
See all newsAC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health